Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer
Authors
Keywords
Lung metastases, Stereotactic ablative radiotherapy, Tumor response, Biomarker, Immunology
Journal
Journal of Translational Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-11
DOI
10.1186/s12967-019-1872-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non–Small-cell Lung Cancer
- (2018) Alexander L. Chin et al. Clinical Lung Cancer
- Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy
- (2018) Ye Zheng et al. Clinical Lung Cancer
- Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer
- (2018) William A. Stokes et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline
- (2018) Bryan J. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs
- (2018) Qinghua Xu et al. Journal of Thoracic Oncology
- Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer
- (2018) Souptik Barua et al. LUNG CANCER
- Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer
- (2018) Robert D. Timmerman et al. JAMA Oncology
- Initial Results of a Multicenter Phase II Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer
- (2018) Philip Sutera et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer
- (2017) Gregory Tiesi et al. JOURNAL OF SURGICAL RESEARCH
- Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligometastases
- (2017) Joyce E. Lodeweges et al. Journal of Thoracic Oncology
- Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial
- (2017) Bing Sun et al. Journal of Thoracic Oncology
- Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by 18 FDG-PET/CT
- (2017) Rosario Mazzola et al. Journal of Thoracic Oncology
- Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases
- (2017) Margriet Kwint et al. LUNG CANCER
- Radiotherapy and immunotherapy: a beneficial liaison?
- (2017) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- Increased PD-1 + and TIM-3 + TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients
- (2017) Hyun-Bae Jie et al. Cancer Immunology Research
- Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness
- (2017) Qiuji Wu et al. Frontiers in Immunology
- Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients
- (2016) Y. Cho et al. ANNALS OF ONCOLOGY
- Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer
- (2016) T. Kinoshita et al. ANNALS OF ONCOLOGY
- Cone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response
- (2016) Rosario Mazzola et al. BRITISH JOURNAL OF RADIOLOGY
- Radiotherapy combination opportunities leveraging immunity for the next oncology practice
- (2016) Fernanda G. Herrera et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
- (2016) Chad Tang et al. CLINICAL CANCER RESEARCH
- Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients
- (2016) Pamela Samson et al. Journal of Thoracic Oncology
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients
- (2016) Athanasios Kotsakis et al. Scientific Reports
- Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer
- (2015) Keith L. Knutson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
- (2015) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
- (2015) Joe Y Chang et al. LANCET ONCOLOGY
- Density of Tumor-Infiltrating FOXP3+ T Cells as a Response Marker for Induction Chemoradiotherapy and a Potential Prognostic Factor in Patients Treated with Trimodality Therapy for Locally Advanced Non-Small Cell Lung Cancer
- (2014) Hiroyuki Tao et al. Annals of Thoracic and Cardiovascular Surgery
- Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2014) J. R. Brown et al. CLINICAL CANCER RESEARCH
- PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2014) H. Wimberly et al. Cancer Immunology Research
- Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy
- (2013) Guohong Song et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Changes of CD4+CD25+FOXP3+ and CD8+CD28− regulatory T cells in non-small cell lung cancer patients undergoing surgery
- (2013) Cheng Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Helper T cell diversity and plasticity
- (2012) Shingo Nakayamada et al. CURRENT OPINION IN IMMUNOLOGY
- Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer
- (2011) Giorgio V. Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential B7–CD28 Costimulatory Requirements for Stable and Inflationary Mouse Cytomegalovirus-Specific Memory CD8 T Cell Populations
- (2011) Ramon Arens et al. JOURNAL OF IMMUNOLOGY
- Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells
- (2011) Hiroyuki Tao et al. LUNG CANCER
- Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer
- (2011) Koji Yasuda et al. Radiation Oncology
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- 21 years of Biologically Effective Dose
- (2010) J F Fowler BRITISH JOURNAL OF RADIOLOGY
- Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer
- (2010) Joji Kitayama et al. Radiation Oncology
- Local Surgical, Ablative, and Radiation Treatment of Metastases
- (2009) R. D. Timmerman et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CD28 and CTLA-4 coreceptor expression and signal transduction
- (2009) Christopher E. Rudd et al. IMMUNOLOGICAL REVIEWS
- CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients
- (2009) Bülent Karagöz et al. MEDICAL ONCOLOGY
- CD28− T cells: their role in the age-associated decline of immune function
- (2009) Nan-ping Weng et al. TRENDS IN IMMUNOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started